Seeing Is Believing
GMED is currently covered by 16 analysts with an average price target of $62.07. This is a potential upside of $10.63 (20.66%) from yesterday's end of day stock price of $51.44.
Globus Medical's activity chart (see below) currently has 169 price targets and 155 ratings on display. The stock rating distribution of GMED is 46.81% BUY, 51.06% HOLD and 2.13% SELL.
Analysts average stock forecasts to be materialized ratio is 78.21% with an average time for these price targets to be met of 202.63 days.
Highest price target for GMED is $86, Lowest price target is $58, average price target is $62.07.
Most recent stock forecast was given by RYAN ZIMMERMAN from BTIG on 18-Mar-2024. First documented stock forecast 28-Aug-2012.
Currently out of the existing stock ratings of GMED, 22 are a BUY (46.81%), 24 are a HOLD (51.06%), 1 are a SELL (2.13%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
60
$8.56 (16.64%)
1 months 7 days ago
7/9 (77.78%)
$8.35 (16.17%)
64
Hold
60
$8.56 (16.64%)
58
2 months 4 days ago
11/22 (50%)
$5 (9.09%)
378
Buy
64
$12.56 (24.42%)
61
2 months 4 days ago
5/7 (71.43%)
$9 (16.36%)
104
Buy
75
$23.56 (45.80%)
70
6 months 5 days ago
6/11 (54.55%)
$23.69 (46.17%)
208
Buy
86
$34.56 (67.19%)
77
6 months 13 days ago
14/19 (73.68%)
$32.8 (61.65%)
232
What is GMED (Globus Medical) average time for price targets to be met?
Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?
Which analyst has the most public recommendations on GMED (Globus Medical)?
Which analyst is the currently most bullish on GMED (Globus Medical)?
Which analyst is the currently most reserved on GMED (Globus Medical)?